Grogan Jane's Insider Trades & SAST Disclosures
Grogan Jane's most recent trade in Biogen Inc was a trade of 5,620 Restricted Stock Unit done . Disclosure was reported to the exchange on Feb. 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Grogan Jane.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Inc | Jane Grogan | Head of Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 5,620 | 5,620 | - | - | Restricted Stock Unit | |
| Biogen Inc | Jane Grogan | Head of Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,385 | 1,876 (0%) | 0% | 0 | Common Stock | |
| Biogen Inc | Jane Grogan | Head of Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,385 | 2,770 | - | - | Restricted Stock Unit | |
| Biogen Inc | Jane Grogan | Head of Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.35 per share. | 06 Feb 2025 | 443 | 1,433 (0%) | 0% | 141.3 | 62,618 | Common Stock |
| Biogen Inc | Jane Grogan | Head of Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 695 | 1,390 | - | - | Restricted Stock Unit | |
| Biogen Inc | Jane Grogan | Head of Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 695 | 695 (0%) | 0% | 0 | Common Stock | |
| Biogen Inc | Jane Grogan | Head of Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.79 per share. | 01 Nov 2024 | 204 | 491 (0%) | 0% | 173.8 | 35,453 | Common Stock |
| Biogen Inc | Grogan Jane | Head of Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 4,155 | 4,155 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges